Sante Ventures
Institutional venture firm, based in Austin, Texas, reporting $954M of fund assets on its funds' Form ADV filings.
Composed from this organization's classification, location and filed figures.
27 additional team members, 7 additional co-investors and affiliates, 14 additional investments, funds and LPs, 16 events, 1 verified contact (1 firm phone)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 5 companiesnew in 12 months
5 new companies in the last 12 months. Latest round Sonire Therapeutics Series A ($18M round, led) on 15 Apr 2026.
A firm writing cheques this quarter is one a founder can pitch now.
- 2 of 6enter at seed or A
Enters mostly at seed to Series A: 4 of 6 first entries on record, in line with the series a stage its site states.
rounds to 15 Apr 2026 · Tells a founder whether their round is one this firm writes.
People to know
View all people- PartnerWhy: Partner: part of the investment decisionNo route on file yet
- Managing DirectorWhy: Managing directorNo route on file yet
- Managing MemberWhy: Named with investment responsibilityNo route on file yet
Relationship network
59 connected entities13 observed rounds3 dated rounds shown here, 2026
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Capital provider
- Fund or vehicle
- Person
›How strength and recency are read
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Sante Ventures: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Sante Ventures
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
13 companies on record, 5 new in 12 months
Investments on record
What these amounts mean“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.Acquired, Public, Exited and Active are what the firm’s own portfolio card says, read on the date shown when you hover the chip; they are not deal dates. A company with no chip is one whose card states no outcome: DFX does not assume it is active.| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Sonire Therapeutics | Series A · Series A | lead | unknown | $18.0M | unknown | Apr 15, 2026 | Fact Press release |
| E2 (Endovascular Engineering) | Series C · Series C | participant | unknown | $80.0M | unknown | Apr 7, 2026 | Fact Press release |
| beHuman | Seed Round · Seed | lead | Kevin Lalande (confirmed) | $4.0M | unknown | Feb 4, 2026 | Fact Press release |
Stated thesis versus observed behaviour
- Sectors
- ai, healthcare, biotech, medtech
- Stages
- series a
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Team
30 current, 6 departed
Decision makers
- Casey Cunningham · PartnerWhy this person: Partner: part of the investment decision; Named with investment responsibility
- James Eadie · Managing DirectorWhy this person: Managing director; Named with investment responsibility
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
Investment team
How the team is orderedPartners who lead rounds first (rounds led, then deals attributed, then seniority), then the rest of the investment team, then investor relations, finance and operations. A person named by two sources under two spellings is shown once.- Managing Member · 1 deal attributed
- Partner · 2 deals attributed
- Managing Director · 2 deals attributed
5 departed (kept with end dates)
- Steven Earl Seach · Operating Partner And Chief Operating Officer · Sep 1, 2012 to Dec 2, 2014 Inference
- Alfred Morse Macdaniel · General Counsel · Oct 1, 2014 to Mar 26, 2015 Inference
- David Ebert Kaufman · Chief Operating Officer · Jan 1, 2019 to Mar 30, 2023 Inference
Contacts
1 firm phone on record, each with its source. Values open with the complete profile.
Funds and LPs
7 vehicles, 1 LPs disclosed
Funds and vehicles
What these amounts meanGAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Santé Health Ventures IV, LP | Fund | 2022 adv first reported | Active deployment | $307M Mar 30, 2026 | 26 | $0 of $250M | Mar 31, 2021 |
| Santé Health Ventures IV Parallel a, LP | Feeder or parallel | 2022 adv first reported | Active deployment | $126M Mar 30, 2026 | 1 | unknown | unknown |
| Santé Health Ventures III Parallel a, L.P. | Feeder or parallel | 2020 adv first reported | Mature | $123M Mar 30, 2026 | 1 | unknown | unknown |
Limited partners
- 2 commitments to 2 funds · $150M disclosed
Known LPs and allocators
What these amounts and dates areEach commitment is counted once across the pension tape and the allocator graph. A commitment date prints only when the source printed one; otherwise the row carries the report date. A foundation’s 990-PF line is a holding at fair value, never a commitment. Rows without a fund on the venture graph are commitments to this manager.| Allocator | Type | Fund | Amount | Date | Source |
|---|---|---|---|---|---|
| Pennsylvania Public School Employees' Retirement System | STATE RETIREMENT SYSTEM | Santé Health Ventures IV, LP | $75.0M committed | reported as of Dec 31, 2025 | Fact Pension disclosure |
| Pennsylvania Public School Employees' Retirement System | STATE RETIREMENT SYSTEM | Sante Health Ventures III, LP | $75.0M committed | reported as of Dec 31, 2025 | Fact Pension disclosure |
Relationships across DFX
10 co-investors · on 1 other DFX graph
Co-investors
- 2026-04-151 shared deal · one time · this firm led 1
- 2026-04-071 shared deal · one time · they led 1
- 2026-04-071 shared deal · one time
Across DFX and the capital chainon 1 other DFX graph · 11 capital paths ShowHide
- The same institution is held on Allocators, matched by identifier. See which records
Sante Ventures is the same institution as 1 record in Allocators.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Sante Ventures sits on 11 traced paths of capital across the graphs.
DFX traced 11 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Evidence and history
21 dated events, 79 observations from 3 sources
Timeline
- Mar 30, 2026Santé Health Ventures V, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $329,243,207
- Mar 30, 2026SHV Opportunities a, LLC first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $25,276,172
- Mar 30, 2023David Ebert Kaufman (Chief Operating Officer) no longer on Schedule A of Sante Ventures
- Mar 31, 2022Santé Health Ventures IV Parallel a, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $76,973,570
- Mar 31, 2022Santé Health Ventures IV, LP first reported on Form ADV by Sante Ventures (Venture Capital Fund), GAV $185,993,880
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 30, 2026 · 9 private fundsShowHide
Website description: Privately Held Companies
- Headquarters
- Austin, TXadviserinfo.sec.gov
- Office address
- unknownadviserinfo.sec.gov
- Business phone
- unknownadviserinfo.sec.gov
- Website
- sante.com
- SEC adviser type
- Exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- Venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 30, 2026
- Private funds reported
- 9 (9 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $1.3Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- French Investments I, LLC (Member), owns 25% to 50%
Classification history
Classification history
Every classification this record has carried2 on recordShowHide
- Sep 23, 2026Institutional venture firm (confirmed, 95%)Venture manager, reported GAV $954M across 7 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%)Venture manager, reported GAV $977M across 7 vehicles
Evidence
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | VC exemption, VC funds reported | Mar 30, 2026 | Fact | Form ADV |
| SEC exemption claimed | Venture capital fund adviser | Mar 30, 2026 | Fact | Form ADV |
| SEC exemption claimed | Venture capital fund adviser | Mar 27, 2024 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 30, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 30, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 27, 2024 | Fact | Form ADV |
| First Form ADV filing | 2012-03-30 | Mar 30, 2026 | Fact | Form ADV |
| First Form ADV filing | 2012-03-30 | Mar 27, 2024 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-29 | Sep 30, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-25 | Sep 26, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-23 | Sep 24, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-21 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-22 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-30 | Mar 30, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-30 | Mar 30, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2024-03-27 | Mar 27, 2024 | Fact | Form ADV |
| SEC status | ERA - Active | Mar 30, 2026 | Fact | Form ADV |
| SEC status effective | 2012-03-30 | Mar 30, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 30, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 27, 2024 | Fact | Form ADV |
| Business phone | Mar 30, 2026 | Fact | Form ADV | |
| Business phone | Mar 27, 2024 | Fact | Form ADV | |
| Contact page url | Sep 30, 2026 | Fact | ||
| Contact page url | Sep 16, 2026 | Fact | ||
| Description | Sep 30, 2026 | Fact | ||
| Description | Sep 16, 2026 | Fact | ||
| Description | Sep 12, 2026 | Fact | ||
| Headquarters | Austin, TX | Mar 30, 2026 | Fact | Form ADV |
| Headquarters | Austin, TX | Mar 27, 2024 | Fact | Form ADV |
| Office address | Mar 30, 2026 | Fact | Form ADV | |
| Office address | Mar 27, 2024 | Fact | Form ADV | |
| Legal form | Limited Liability Company | Mar 30, 2026 | Fact | Form ADV |
| Legal form | Limited Liability Company | Mar 27, 2024 | Fact | Form ADV |
| Portfolio page | Sep 30, 2026 | Fact | ||
| Portfolio page | Sep 16, 2026 | Fact | ||
| Portfolio page | Sep 12, 2026 | Fact | ||
| Private funds reported | 9 | Mar 30, 2026 | Fact | Form ADV |
| Private funds reported | 9 | Mar 30, 2026 | Fact | Form ADV |
| Private funds reported | 7 | Mar 27, 2024 | Fact | Form ADV |
| Private fund gross assets (reported) | $1.3B | Mar 30, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $1.3B | Mar 30, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $977M | Mar 27, 2024 | Fact | Form ADV |
| Schedule a diff | sadiff-1 | Sep 14, 2026 | Fact | Form ADV |
| Stated sectors | AI, healthcare, biotech, medtech “sector words on the home page” | Sep 30, 2026 | Fact | |
| Stated sectors | AI, healthcare, biotech, medtech “sector words on the home page” | Sep 16, 2026 | Fact | |
| Stated sectors | AI, healthcare, biotech, medtech “sector words on the home page” | Sep 12, 2026 | Fact | |
| Stated stages | Series a “stage words on the home page” | Sep 30, 2026 | Fact | |
| Stated stages | Series a “stage words on the home page” | Sep 16, 2026 | Fact | |
| Stated stages | Series b “stage words on the home page” | Sep 12, 2026 | Fact | |
| Team page | Sep 30, 2026 | Fact | ||
| Team page | Sep 16, 2026 | Fact | ||
| Team page | Sep 12, 2026 | Fact | ||
| Venture funds reported | 9 | Mar 30, 2026 | Fact | Form ADV |
| Venture funds reported | 9 | Mar 30, 2026 | Fact | Form ADV |
| Venture funds reported | 7 | Mar 27, 2024 | Fact | Form ADV |
| Website | Mar 30, 2026 | Fact | Form ADV | |
| Website | Mar 27, 2024 | Fact | Form ADV | |
| Site title | Sep 30, 2026 | Fact | ||
| Site title | Sep 16, 2026 | Fact | ||
| Site title | Sep 12, 2026 | Fact |
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, confirmedShowHide
Venture manager, reported GAV $954M across 7 vehicles
- importance
- gav: 0.6 · funds: 0.58 · people: 0.92 · investments: 0.41 · co investors: 0.4
- active deployment
- investments 12m: 0.63 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 0 · latest investment at: 2026-04-15
- emerging manager
- fund count: 7 · reported gav: $954M · first adv filing: 2012-03-30 · years since first filing: 14.5
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Fits
- score 27.8confidence 90%Why: sector fit; geography fit; activity
Scored by DFX match engines from the record's observed portfolio, stage, geography and recent activity. A fit is a reason to look, not a mandate; the blockers say what the model could not confirm. Names and the evidence sentences show with the names on this page.
Record history
- Adviser's first ADV filing2012-03-30source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.